SCHEMBL29438855

SCHEMBL29438855

COc1ccc(CN(C)S(=O)(=O)c2cnc(Nc3cccc(C(F)(F)F)c3)c(Br)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 2/20 0.48
▸ MAPT P10636 3/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ GAA P10253 1/20 0.43
▸ MMP1 P03956 3/20 0.43
▸ MMP9 P14780 3/20 0.43
▸ MMP13 P45452 3/20 0.43
▸ NAMPT P43490 1/20 0.42
▸ APP P05067 1/20 0.42
▸ LMNA P02545 2/20 0.42
▸ AR P10275 1/20 0.41
▸ BMP1 P13497 1/20 0.41
▸ P2RX3 P56373 1/20 0.41
▸ ADAM17 P78536 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22718052 1.00 KDR (0.48) KDRMAPTKDM4EMEN1KMT2A
SCHEMBL24497433 0.90 BMP1 (0.47) KDRMAPTKDM4EKMT2AGAA
SCHEMBL29206926 0.87 NAMPT (0.46) KDM4EMEN1KMT2AMMP1MMP9
SCHEMBL30876275 0.87 NAMPT (0.46) KDM4EMEN1KMT2AMMP1MMP9
SCHEMBL22843404 0.85 MAPT (0.54) MAPTKDM4EMEN1KMT2AGAA
SCHEMBL29648392 0.85 BMP1 (0.44) MAPTKDM4EMEN1KMT2AGAA
SCHEMBL24497371 0.85 BMP1 (0.44) MAPTKDM4EMEN1KMT2AGAA
SCHEMBL22718120 0.84 KDR (0.43) KDRMAPTKDM4EMEN1KMT2A
SCHEMBL29438843 0.84 KDR (0.43) KDRMAPTKDM4EMEN1KMT2A
SCHEMBL30876228 0.83 BMP1 (0.47) MAPTKDM4EGAAMMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119954725-A TEAD inhibitors and uses thereof 医肯纳肿瘤学公司 2025-05-09 — — CN disclosed
CN-114466839-B TEAD inhibitors and uses thereof 医肯纳肿瘤学公司 2025-01-07 — — CN disclosed
EP-3976194-A2 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback